Robert I. Parker

Bone marrow involvement in young patients with non‐Hodgkin's lymphoma: The importance of multiple bone marrow samples for accurate staging

Theresa B. Haddy, Robert I. Parker, Ian Magrath · Medical and Pediatric Oncology · 1989 · 69 citations

Pathology, Marrow Involvement, Young Patients +16

Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I

Theodore C. Friedman, Pamela M. Thomas, Thomas A. Fleisher et al. · The American Journal of Medicine · 1991 · 64 citations

Autoimmune Disease, Autoantibody Production, Disease Mechanism +12

Hematologic Aspects of Mastocytosis: II: Management of Hematologic Disorders in Association with Systemic Mast Cell Disease

Robert I. Parker · Journal of Investigative Dermatology · 1991 · 56 citations

Allergy, Hematologic Aspects, Mast Cell Disorder +4

Hematologic improvement in a patient with gaucher disease on long‐term enzyme replacement therapy: Evidence for decreased splenic sequestration and improved red blood cell survival

Robert I. Parker, Elizabeth J. Read, Norman W. Barton et al. · American Journal of Hematology · 1991 · 33 citations

Randomized, Double-Blind, Crossover, Placebo-Controlled Trial of Intravenous Ondansetron for the Prevention of Intrathecal Chemotherapy-Induced Vomiting in Children

Robert I. Parker, Devina Prakash, Rosemary A. Mahan et al. · ˜The œAmerican journal of pediatric hematology/oncology · 2001 · 31 citations